![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
August 16, 2013
Sanofi raised the price of its Lantus insulin vials by almost 15 percent for the second this time this year. Novo Nordisk may follow suit as the two face increased generic competition.
Bloomberg
Bloomberg
Upcoming Events
-
21Oct